Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000388	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Supplementary Application	2020-08-21	Sanofi-aventis groupe	Sanofi-Aventis Groupe	Filed	2020-09-02	view
JYHB1301024	注射用拉布立海	Rasburicase	Lyophilized	Chemical Drugs	Supplementary Application	2013-09-26	Sanofi-aventis groupe	Sanofi-Aventis Groupe	Approval Completed-Pending Certificated	2014-09-25	view
JXSS1900067	Dupilumab注射液	dupilumab	Injection	Biological Products	Import Drug Application	2019-12-25	Sanofi-aventis groupe	Sanofi-Aventis Groupe	Certificate Issued	2020-06-22	view
JXSL1200016	AVE0005注射液	aflibercept	Injection	Biological Products	Import Drug Application	2012-03-28	sanofi-aventis groupe	Sanofi-Aventis Groupe	Certificate Issued	2014-08-13	view
JXSL1200015	AVE0005注射液	aflibercept	Injection	Biological Products	Import Drug Application	2012-03-31	sanofi-aventis groupe	Sanofi-Aventis Groupe	Certificate Issued	2014-08-13	view